Abstract
Motor neuron disease is clinically characterized by progressive muscle wasting leading to total muscle paralysis. In the most prominent disease, amyotrophic lateral sclerosis, or ALS, a long history of pathological study has firmly established that the primary lesion site is in spinal and cortical motor neurons. Although widespread loss of these neurons is seen late in the pathogenic progression, the earliest detectable abnormalities are aberrant accumulations of neurofilaments in cell bodies and proximal axons. To test whether accumulation of neurofilaments directly contributes to the pathogenic process, transgenic mice that produce high levels of neurofilaments in motor neurons have been generated. These transgenic mice show most of the hallmarks observed in motor neuron disease, including swollen perikarya with eccentrically localized nuclei, proximal axonal swellings, axonal degeneration and severe skeletal muscle atrophy. These data indicate that excessive accumulation of neurofilaments can trigger selective motor neuron failure. Since such accumulation is seen both in sporadic and familial ALS, it is almost certain to be a key intermediate in the pathway of pathogenesis leading to neuronal loss.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.